Summary & Overview
CPT 3062F: Positive Macroalbuminuria Urine Test
CPT code 3062F denotes documentation and review of a positive macroalbuminuria urine test, a marker of significant albuminuria often reflecting diabetic kidney damage. Nationally, tracking and properly documenting macroalbuminuria is important for diabetes quality metrics, kidney disease identification, and clinical management decisions that may alter glycemic or renal-protective therapies. This code signals both a diagnostic laboratory finding and the provider’s clinical acknowledgment and action planning.
Key payers in typical coverage analyses include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code’s clinical context, typical sites of service, and how it fits into diabetes monitoring workflows. The publication summarizes common billing and documentation considerations, describes the clinical implications of a positive macroalbuminuria result, and outlines what to expect in payer coverage discussions and quality reporting programs.
This report is intended for clinicians, billing professionals, and policy analysts seeking a compact reference on CPT code 3062F, its role in diabetes and kidney care, and the operational implications for outpatient practice and quality measurement.
Billing Code Overview
CPT code 3062F documents a positive macroalbuminuria urine test indicating very high levels of albumin in the urine, commonly associated with kidney damage from diabetes. The record describes that the provider documents and reviews the positive macroalbuminuria result and may adjust the patient’s diabetes medication based on the findings.
Service Type: Diagnostic urine test with clinical documentation and medication management consideration
Typical Site of Service: Outpatient clinic or ambulatory care setting, including primary care and endocrinology visits
Clinical & Coding Specifications
Clinical Context
A 58-year-old patient with type 2 diabetes presents for a routine diabetes management visit in an outpatient primary care clinic. The clinician orders a urine macroalbuminuria test to assess for significant albuminuria consistent with diabetic kidney disease. A spot urine sample is collected in the clinic laboratory or point-of-care testing area. The laboratory performs the macroalbuminuria assay and returns a positive result indicating markedly elevated urinary albumin. The provider documents review of the positive test in the medical record, discusses implications with the patient, evaluates kidney function and blood pressure control, and may adjust antihyperglycemic or antihypertensive medication based on the clinical assessment and results. Typical site of service is an outpatient clinic or physician office; collection can occur in a primary care office, endocrinology clinic, or outpatient laboratory. Common payors include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, BUCA, and Medicare.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
GC | Documentation of medical necessity by resident supervisor is present; student performed service | Use when a resident documents that the teaching physician provided the required documentation for the service |
PO |